<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medalphabet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский алфавит</journal-title><trans-title-group xml:lang="en"><trans-title>Medical alphabet</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-5631</issn><issn pub-type="epub">2949-2807</issn><publisher><publisher-name>ООО «Альфмед»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33667/2078-5631-20258-96-99</article-id><article-id custom-type="elpub" pub-id-type="custom">medalphabet-4368</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Случай развития грибовидного микоза у пациента с наличием в анамнезе поверхностнораспространяющейся меланомы кожи</article-title><trans-title-group xml:lang="en"><trans-title>A case of fungal mycosis in a patient with a history of superficially spreading melanoma of the skin</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1909-222X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Окладникова</surname><given-names>Е.  В.</given-names></name><name name-style="western" xml:lang="en"><surname>Okladnikova</surname><given-names>E.  V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Окладникова Евгения Владимировна, к.м.н., доцент кафедры патологической физиологии им. В.В. Иванова</p><p>Красноярск</p></bio><bio xml:lang="en"><p>Okladnikova Evgenia V., PhD Med, associate professor at Dept of Pathological Physiology named after V.V. Ivanov</p><p>Krasnoyarsk</p></bio><email xlink:type="simple">farmasis@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6363-5941</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Есимбекова</surname><given-names>А.  Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Esimbekova</surname><given-names>A. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Есимбекова Александра Рашидовна, ассистент кафедры патологической физиологии им. В.В. Иванова</p><p>Красноярск</p></bio><bio xml:lang="en"><p>Esimbekova Alexandra R., assistant PhD, associate professor at Dept of Pathological Physiology named after V.V. Ivanov</p><p>Krasnoyarsk</p></bio><email xlink:type="simple">aleksandra.esimbekova.96@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Красноярский государственный медицинский университет имени профессора В.Ф. Войно-Ясенецкого» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Krasnoyarsk State Medical University named after Professor V. F. Voyno-Yasenetsky</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>04</day><month>06</month><year>2025</year></pub-date><volume>0</volume><issue>8</issue><issue-title>Дерматология (1)</issue-title><fpage>96</fpage><lpage>99</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Окладникова Е.В., Есимбекова А.Р., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Окладникова Е.В., Есимбекова А.Р.</copyright-holder><copyright-holder xml:lang="en">Okladnikova E.V., Esimbekova A.R.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-alphabet.com/jour/article/view/4368">https://www.med-alphabet.com/jour/article/view/4368</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования. Грибовидный микоз (ГМ) представляет собой опухолевую трансформацию Т-лимфоцитов кожи и относится к кожным Т-клеточным лимфомам. Этиология и патогенез ГМ неизвестны, ранняя диагностика на основании только осмотра пациента затруднительна вследствие разнообразия кожных элементов при ГМ. Описаны случаи развития злокачественных новообразований различных локализаций у пациентов с ГМ вследствие развивающегося дефицита Т-клеточного звена иммунитета. В научной литературе мало описаны случаи развития ГМ у больных с меланомой в анамнезе.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В представленной работе рассматривается клинический случай развития ГМ у женщины 82 лет через 4 года после диагностики и хирургического лечения поверхностно-распространяющейся меланомы кожи.</p></sec><sec><title>Результаты</title><p>Результаты. С целью диагностики ГМ и дифференциальной диагностики с другой патологией кожи, оптимальным является использование иммуногистохимического исследования.</p></sec><sec><title>Выводы</title><p>Выводы. Представленный клинический случай показывает необходимость длительного, возможно пожизненного, наблюдения пациентов с меланомой в анамнезе врачом-дерматологом, а также проявление онкологической настороженности врачами других специальностей с целью профилактики развития злокачественных новообразований кожи и других органов.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Purpose of the study</title><p>Purpose of the study. Mycosis fungoides (MF) is a tumor transformation of T-lymphocytes of the skin and belongs to cutaneous T-cell lymphomas. The etiology and pathogenesis of MF are unknown; early diagnosis based only on examination of the patient is difficult due to the variety of skin elements in MF. Cases of the development of malignant neoplasms of various localizations in patients with MF due to the developing deficiency of the T-cell component of immunity have been described. The scientific literature contains few descriptions of cases of the development of MF in patients with a history of melanoma.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The presented work examines a clinical case of the development of MF in an 82-year-old woman 4 years after diagnosis and surgical treatment of superficial spreading melanoma of the skin.</p></sec><sec><title>Results</title><p>Results. For the purpose of diagnosing MF and differential diagnosis with other skin pathologies, the use of immunohistochemical research is optimal.</p></sec><sec><title>Conclusions</title><p>Conclusions. The presented clinical case shows the need for long-term, possibly lifelong, observation of patients with a history of melanoma by a dermatologist, as well as the manifestation of oncological vigilance by doctors of other specialties in order to prevent the development of malignant neoplasms of the skin and other organs.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>Грибовидный микоз</kwd><kwd>Т-клеточная лимфома</kwd><kwd>меланома</kwd><kwd>клинический случай</kwd></kwd-group><kwd-group xml:lang="en"><kwd>mycosis fungoides</kwd><kwd>T-cell lymphoma</kwd><kwd>melanoma</kwd><kwd>case report</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Hristov A.C., Tejasvi T., Wilcox R.A. Cutaneous T-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023; 98 (1): 193–209. DOI: 10.1002/ajh.26760</mixed-citation><mixed-citation xml:lang="en">Hristov A.C., Tejasvi T., Wilcox R.A. Cutaneous T-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023; 98 (1): 193–209. DOI: 10.1002/ajh.26760</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Almaani N., Farhan F., Bani Hamad S., Abuhawileh E.A., Koubaitary L., Ahram M., Aladily T.N. Genetic predisposition to early mycosis fungoides: investigating genetic polymorphisms in tissue-resident memory T-cell genes. J Int Med Res. 2024; 52 (3): 3000605241239034. DOI: 10.1177/03000605241239034</mixed-citation><mixed-citation xml:lang="en">Almaani N., Farhan F., Bani Hamad S., Abuhawileh E.A., Koubaitary L., Ahram M., Aladily T.N. Genetic predisposition to early mycosis fungoides: investigating genetic polymorphisms in tissue-resident memory T-cell genes. J Int Med Res. 2024; 52 (3): 3000605241239034. DOI: 10.1177/03000605241239034</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Behbahani S, Yeh CJ, Fernandez JM, Chen ST. Gender differences in clinical presentation, treatment, and outcomes in mycosis fungoides. J Am Acad Dermatol. 2022; 86 (1): 174–177. DOI: 10.1016/j.jaad.2021.01.026</mixed-citation><mixed-citation xml:lang="en">Behbahani S, Yeh CJ, Fernandez JM, Chen ST. Gender differences in clinical presentation, treatment, and outcomes in mycosis fungoides. J Am Acad Dermatol. 2022; 86 (1): 174–177. DOI: 10.1016/j.jaad.2021.01.026</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Vitiello P., Sagnelli C., Ronchi A., Franco R., Caccavale S., Mottola M., Pastore F., Argenziano G., Creta M., Calogero A., Fiorelli A., Casale B., Sica A. Multidisciplinary Approach to the Diagnosis and Therapy of Mycosis Fungoides. Healthcare (Basel). 2023; 11 (4): 614. DOI: 10.3390/healthcare11040614</mixed-citation><mixed-citation xml:lang="en">Vitiello P., Sagnelli C., Ronchi A., Franco R., Caccavale S., Mottola M., Pastore F., Argenziano G., Creta M., Calogero A., Fiorelli A., Casale B., Sica A. Multidisciplinary Approach to the Diagnosis and Therapy of Mycosis Fungoides. Healthcare (Basel). 2023; 11 (4): 614. DOI: 10.3390/healthcare11040614</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Sayed K. S., Mohammed F.N., Abdel Hay R.M., Amr K.S., AlOrbani A.M. Cyclooxygenase 2 Gene Polymorphisms –765G&gt;C and –1195A&gt;G and Mycosis Fungoides Risk. Dermatology. 2021; 237 (1): 17–21. DOI: 10.1159/000504840</mixed-citation><mixed-citation xml:lang="en">Sayed K. S., Mohammed F.N., Abdel Hay R.M., Amr K.S., AlOrbani A.M. Cyclooxygenase 2 Gene Polymorphisms –765G&gt;C and –1195A&gt;G and Mycosis Fungoides Risk. Dermatology. 2021; 237 (1): 17–21. DOI: 10.1159/000504840</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Olszewska B., Gleń J., Zabłotna M., Nowicki R. J., Sokołowska-Wojdyło M. The polymorphisms of IL 6/STAT3 signaling pathway may contribute to cutaneous T-cell lymphomas susceptibility. Arch Dermatol Res. 2021; 313 (1): 25–31. DOI: 10.1007/s00403 020 02062 5</mixed-citation><mixed-citation xml:lang="en">Olszewska B., Gleń J., Zabłotna M., Nowicki R. J., Sokołowska-Wojdyło M. The polymorphisms of IL 6/STAT3 signaling pathway may contribute to cutaneous T-cell lymphomas susceptibility. Arch Dermatol Res. 2021; 313 (1): 25–31. DOI: 10.1007/s00403 020 02062 5</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kołkowski K., Jolanta Gleń, Berenika Olszewska, Monika Zabłotna, Nowicki R. J., Małgorzata Sokołowska-Wojdyło. Interleukin 17 Genes Polymorphisms are Significantly Associated with Cutaneous T-cell Lymphoma Susceptibility. Acta Derm Venereol. 2022; 102: adv00777. DOI: 10.2340/actadv.v102.2416</mixed-citation><mixed-citation xml:lang="en">Kołkowski K., Jolanta Gleń, Berenika Olszewska, Monika Zabłotna, Nowicki R. J., Małgorzata Sokołowska-Wojdyło. Interleukin 17 Genes Polymorphisms are Significantly Associated with Cutaneous T-cell Lymphoma Susceptibility. Acta Derm Venereol. 2022; 102: adv00777. DOI: 10.2340/actadv.v102.2416</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Prochazkova M., Chevret E., Mainhaguiet G., Sobotka J., Vergier B., Belaud-Rotureau M.A., Beylot-Barry M., Merlio J.P. Common chromosomal abnormalities in mycosis fungoides transformation. Genes Chromosomes Cancer. 2007; 46 (9): 828–38. DOI: 10.1002/gcc.20469</mixed-citation><mixed-citation xml:lang="en">Prochazkova M., Chevret E., Mainhaguiet G., Sobotka J., Vergier B., Belaud-Rotureau M.A., Beylot-Barry M., Merlio J.P. Common chromosomal abnormalities in mycosis fungoides transformation. Genes Chromosomes Cancer. 2007; 46 (9): 828–38. DOI: 10.1002/gcc.20469</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Plunkett K.R., Armitage J.D., Inderjeeth A. J., McDonnell A.M., Waithman J., Lau PKH. Tissue-resident memory T cells in the era of (Neo) adjuvant melanoma management. Front Immunol. 2022; 13: 1048758. DOI: 10.3389/fimmu.2022.1048758</mixed-citation><mixed-citation xml:lang="en">Plunkett K.R., Armitage J.D., Inderjeeth A. J., McDonnell A.M., Waithman J., Lau PKH. Tissue-resident memory T cells in the era of (Neo) adjuvant melanoma management. Front Immunol. 2022; 13: 1048758. DOI: 10.3389/fimmu.2022.1048758</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Рукша Т. Г., Аксененко М.Б., Гырылова С.Н. Злокачественные новообразования кожи: анализ заболеваемости в Красноярском крае, проблемы профилактики и совершенствования ранней диагностики. Вестник дерматологии и венерологии. 2010; (4): 4–9.</mixed-citation><mixed-citation xml:lang="en">Ruksha T.G., Aksenenko M.B., Gyrylova S.N.. Skin cancxer in Krasnoyarsk krai: the problems of prevention and early diagnostics] Vestnik dermatologii i venerologii. 2010; 86 (4): 4–9. (In Russ.). DOI 10.25208/0042 4609 2010 0 04</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Park S. L., Buzzai A., Rautela J., Hor J. L., Hochheiser K., Effern M., McBain N., Wagner T., Edwards J., McConville R., Wilmott J. S., Scolyer R.A., Tüting T., Palendira U., Gyorki D., Mueller S.N., Huntington N.D., Bedoui S., Hölzel M., Mackay L.K., Waithman J., Gebhardt T. Tissue-resident memory CD8+T cells promote melanoma-immune equilibrium in skin. Nature. 2019; 565 (7739): 366–371. DOI: 10.1038/s41586 018 0812 9</mixed-citation><mixed-citation xml:lang="en">Park S. L., Buzzai A., Rautela J., Hor J. L., Hochheiser K., Effern M., McBain N., Wagner T., Edwards J., McConville R., Wilmott J. S., Scolyer R.A., Tüting T., Palendira U., Gyorki D., Mueller S.N., Huntington N.D., Bedoui S., Hölzel M., Mackay L.K., Waithman J., Gebhardt T. Tissue-resident memory CD8+T cells promote melanoma-immune equilibrium in skin. Nature. 2019; 565 (7739): 366–371. DOI: 10.1038/s41586 018 0812 9</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Liu G., Wang Z., Li S. Heterogeneity and plasticity of tissue-resident memory T cells in skin diseases and homeostasis: a review. Front Immunol. 2024; 15: 1378359. DOI: 10.3389/fimmu.2024.1378359.</mixed-citation><mixed-citation xml:lang="en">Liu G., Wang Z., Li S. Heterogeneity and plasticity of tissue-resident memory T cells in skin diseases and homeostasis: a review. Front Immunol. 2024; 15: 1378359. DOI: 10.3389/fimmu.2024.1378359.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Willemsen M., Tio D., Krebbers G., Kasiem F. R., Jaspars E.H., Matos T. R., Bekkenk M.W., Bakker W. J., Luiten R.M. Presence of Skin Tissue-Resident Memory T Cells in Human Nonmalignant and Premalignant Melanocytic Skin Lesions and in Melanoma. Am J Dermatopathol. 2022; 44 (6): 416–423. DOI: 10.1097/DAD.0000000000002184</mixed-citation><mixed-citation xml:lang="en">Willemsen M., Tio D., Krebbers G., Kasiem F. R., Jaspars E.H., Matos T. R., Bekkenk M.W., Bakker W. J., Luiten R.M. Presence of Skin Tissue-Resident Memory T Cells in Human Nonmalignant and Premalignant Melanocytic Skin Lesions and in Melanoma. Am J Dermatopathol. 2022; 44 (6): 416–423. DOI: 10.1097/DAD.0000000000002184</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Hossen M.M., Ma Y., Yin Z., Xia Y., Du J., Huang J. Y., Huang J. J., Zou L., Ye Z., Huang Z. Current understanding of CTLA 4: from mechanism to autoimmune diseases. Front Immunol. 2023; 14: 1198365. DOI: 10.3389/fimmu.2023.1198365</mixed-citation><mixed-citation xml:lang="en">Hossen M.M., Ma Y., Yin Z., Xia Y., Du J., Huang J. Y., Huang J. J., Zou L., Ye Z., Huang Z. Current understanding of CTLA 4: from mechanism to autoimmune diseases. Front Immunol. 2023; 14: 1198365. DOI: 10.3389/fimmu.2023.1198365</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Shin J., Ho Lee D., Lee W. J., Park C. S. Mycosis fungoides development after combined immune checkpoint blockade therapy in a patient with malignant melanoma: a case report. Melanoma Res. 2020; 30 (5): 515–518. DOI: 10.1097/CMR.0000000000000664</mixed-citation><mixed-citation xml:lang="en">Shin J., Ho Lee D., Lee W. J., Park C. S. Mycosis fungoides development after combined immune checkpoint blockade therapy in a patient with malignant melanoma: a case report. Melanoma Res. 2020; 30 (5): 515–518. DOI: 10.1097/CMR.0000000000000664</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Bar-Sela G., Bergman R. Complete regression of mycosis fungoides after ipilimumab therapy for advanced melanoma. JAAD Case Rep. 2015; 1 (2): 99–100. DOI: 10.1016/j.jdcr.2015.02.009</mixed-citation><mixed-citation xml:lang="en">Bar-Sela G., Bergman R. Complete regression of mycosis fungoides after ipilimumab therapy for advanced melanoma. JAAD Case Rep. 2015; 1 (2): 99–100. DOI: 10.1016/j.jdcr.2015.02.009</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang H., Dai Z., Wu W., Wang Z., Zhang N., Zhang L., Zeng W. J., Liu Z., Cheng Q. Regulatory mechanisms of immune checkpoints PD-L1 and CTLA 4 in cancer. J Exp Clin Cancer Res. 2021; 40 (1): 184. DOI: 10.1186/s13046 021 01987 7</mixed-citation><mixed-citation xml:lang="en">Zhang H., Dai Z., Wu W., Wang Z., Zhang N., Zhang L., Zeng W. J., Liu Z., Cheng Q. Regulatory mechanisms of immune checkpoints PD-L1 and CTLA 4 in cancer. J Exp Clin Cancer Res. 2021; 40 (1): 184. DOI: 10.1186/s13046 021 01987 7</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Angelova A., Rommelaere J., Ungerechts G. The Complex Role of Infectious Agents in Human Cutaneous T-Cell Lymphoma Pathogenesis: From Candidate Etiological Factors to Potential Therapeutics. Pathogens. 2024; 13 (3): 184. DOI: 10.3390/pathogens13030184</mixed-citation><mixed-citation xml:lang="en">Angelova A., Rommelaere J., Ungerechts G. The Complex Role of Infectious Agents in Human Cutaneous T-Cell Lymphoma Pathogenesis: From Candidate Etiological Factors to Potential Therapeutics. Pathogens. 2024; 13 (3): 184. DOI: 10.3390/pathogens13030184</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Runge J.S., Bardhi R., Xia Y., Jairath N.K., Wilcox R.A., Tsoi L.C., Tejasvi T. Clinical outcomes in a cohort of patients with cutaneous T-cell lymphoma and COVID 19. JAAD Int. 2022; 8: 52–55. DOI: 10.1016/j.jdin.2022.04.008</mixed-citation><mixed-citation xml:lang="en">Runge J.S., Bardhi R., Xia Y., Jairath N.K., Wilcox R.A., Tsoi L.C., Tejasvi T. Clinical outcomes in a cohort of patients with cutaneous T-cell lymphoma and COVID 19. JAAD Int. 2022; 8: 52–55. DOI: 10.1016/j.jdin.2022.04.008</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Atci T., Yerlioğlu Ak D., Baykal C. Evaluation of secondary malignancies in a large series of mycosis fungoides. An Bras Dermatol. 2024; 99 (3): 370–379. DOI: 10.1016/j.abd.2023.06.004</mixed-citation><mixed-citation xml:lang="en">Atci T., Yerlioğlu Ak D., Baykal C. Evaluation of secondary malignancies in a large series of mycosis fungoides. An Bras Dermatol. 2024; 99 (3): 370–379. DOI: 10.1016/j.abd.2023.06.004</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Sherman S., Kremer N., Dalal A., Solomon-Cohen E., Berkovich E., Noyman Y., Ben-Lassan M., Levi A., Pavlovsky L., Prag Naveh H., Hodak E., Amitay-Laish I. Melanoma Risk is Increased in Patients with Mycosis Fungoides Compared with Patients with Psoriasis and the General Population. Acta Derm Venereol. 2020; 100 (19): adv00346. DOI: 10.2340/00015555–3704</mixed-citation><mixed-citation xml:lang="en">Sherman S., Kremer N., Dalal A., Solomon-Cohen E., Berkovich E., Noyman Y., Ben-Lassan M., Levi A., Pavlovsky L., Prag Naveh H., Hodak E., Amitay-Laish I. Melanoma Risk is Increased in Patients with Mycosis Fungoides Compared with Patients with Psoriasis and the General Population. Acta Derm Venereol. 2020; 100 (19): adv00346. DOI: 10.2340/00015555–3704</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Bhat T. S., Rosman I.S., Cornelius L.A., Musiek A.C. Mycosis fungoides associated with recurrence of malignant melanoma. JAAD Case Rep. 2020; 6 (8): 793–795. DOI: 10.1016/j.jdcr.2020.06.029</mixed-citation><mixed-citation xml:lang="en">Bhat T. S., Rosman I.S., Cornelius L.A., Musiek A.C. Mycosis fungoides associated with recurrence of malignant melanoma. JAAD Case Rep. 2020; 6 (8): 793–795. DOI: 10.1016/j.jdcr.2020.06.029</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Talpur R., Bassett R., Duvic M. Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and Sézary syndrome. Br J Dermatol. 2008; 159 (1): 105–12. DOI: 10.1111/j.1365–2133.2008.08612.x</mixed-citation><mixed-citation xml:lang="en">Talpur R., Bassett R., Duvic M. Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and Sézary syndrome. Br J Dermatol. 2008; 159 (1): 105–12. DOI: 10.1111/j.1365–2133.2008.08612.x</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Ohadi L., Hosseinzadeh F., Dadkhahfar S., Nasiri S. Oncolytic effect of SARS-CoV 2 in a patient with mycosis fungoides: A case report. Clin Case Rep. 2022; 10 (4): e05682. DOI: 10.1002/ccr3.5682</mixed-citation><mixed-citation xml:lang="en">Ohadi L., Hosseinzadeh F., Dadkhahfar S., Nasiri S. Oncolytic effect of SARS-CoV 2 in a patient with mycosis fungoides: A case report. Clin Case Rep. 2022; 10 (4): e05682. DOI: 10.1002/ccr3.5682</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Alsayyah A. Is it mycosis fungoides? A comprehensive guide to reaching the diagnosis and avoiding common pitfalls. Ann Diagn Pathol. 2020; 47: 151546. DOI: 10.1016/j.anndiagpath.2020.151546</mixed-citation><mixed-citation xml:lang="en">Alsayyah A. Is it mycosis fungoides? A comprehensive guide to reaching the diagnosis and avoiding common pitfalls. Ann Diagn Pathol. 2020; 47: 151546. DOI: 10.1016/j.anndiagpath.2020.151546</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Рукша Т. Г., Сергеева Е.Ю., Палкина Н.В., Аксененко М.Б., Комина А.В., Климина Г.М., Белоногов Р.Н. МикроРНК как регуляторы эффектов ультрафиолетового излучения в клетках кожи. Цитология. 2016; 58 (10): 733–743.</mixed-citation><mixed-citation xml:lang="en">Ruksha T.G., Sergeeva E. Yu., Palkina N.V., Aksenenko M.B., Komina A.V., Klimina G.M., Belonogov R.N. MicroRNA as regulators of the effects of ultraviolet radiation in skin cells. Tsitologiya. 2016; 58 (10): 733–743. (In Russ.).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
